参考文献/References:
[1].Sudoh T,Kangawa K,Minamino N.A new natriuretic peptide in porcine brain[J].Nature1988,332(6159):78-81.
[2].Yandle TG.B-type natriuretic peptide circulating forms:analytical and bioactivity issues[J].Clin Chim Acta,2015,448(7):195-205.
[3].Clerico A,Giannoni A,Vittorini S.Thirty years of the heart as an endocrine organ:physiological role and clinical utility of cardiac natriuretic hormones[J].Am J?Physiol Heart Circ Physiol,2011,301(1):H12-20.
[4].Harjola VP,Parissis J,Brunner-La Rocca HP,et al.Comprehensive in-hospital monitoring in acute heart failure:applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association(HFA) of the European Society of Cardiology (ESC)[J].Eur J Heart Fail,2018,20(7):1081-1099.
[5].Brunner-La Rocca HP.Natriuretic peptides in chronic heart failure[J]. Card Fail Rev,2019,5(1):44-49.
[6].M?ckel M,von Haehling S,Vollert JO,et al.Early identification of acute heart failure at the time of presentation:do natriuretic peptides make the difference?[J].Null,2018,5(3):309-315.
[7].Omar HR.Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction[J].Int J?Cardiol,2016,221(7):1116-1122.
[8].Louren?o P,Ribeiro A,Pintalh?o M,et al.Prognostic prediction in acute heart failure patients with extreme BNP values[J].Biomarkers,2017,22(8):715-722.
[9].Carubelli V,Lombardi C,Lazzarini V,et al.N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure[J].J Cardiovasc Med(Hagerstown),2016,17(11):828-839.
[10].Niu JM,Ma ZL,Xie C.Association of plasma B-type natriuretic peptide concentration with myocardial infarct size in patients with acute myocardial infarction[J].Genet?Mol Res,2014,13(3):6177-6183.
[11].Yildirim T,Yildirim SE,Aktoz M.Brain natriuretic peptide levels in acute inferior myocardial infarction[J].J Clin Med Res,2018,10(3):254-259.
[12].Kim DH,Lee SH,Kim SC,et al.The ratio of N-terminal pro-B-type natriuretic peptide to troponin I for differentiating acute coronary syndrome[J].Am J?Emerg Med,2019,37(6):1013-1019.
[13].Bassan F,Bassan R,Esporcatte R,et al.Very long-term prognostic role of admission BNP in non-ST segment elevation acute coronary syndrome[J]. Arq Bras Cardiol,2016,106(3):218-225.
[14].Scott PA,Barry J,Roberts PR.Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias:a meta-analysis[J].Eur J Heart Fail,2009,11(10):958-966.
[15].Levine YC,Rosenberg MA,Mittleman M,et al.B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias[J].Heart Rhythm,2014,11(7):1109-1116.
[16].Wei S,Loyo-Berríos NI,Haigney MC,et al.Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation[J].Circ Cardiovasc Qual Outcomes,2011,4(3):346-354.
[17].Goetze JP,Friis-Hansen L,Rehfeld JF,et al.Atrial secretion of B-type natriuretic peptide[J].Eur Heart J,2006,27(14):1648-1650.
[18].Karaba? Y,Rencuzogullari I,?a?da? M,et al.Association between BNP levels and new-onset atrial fibrillation:a?propensity score approach[J].Herz,2018,43(6):548-554.
[19].Wang R,Wei Y.Levels of plasma N-terminal pro-brain natriuretic peptide and D-dimer on the prognosis of patients with acute cerebral infarction[J].Pak J Med Sci,2018,34(4):855-858.
[20].陈利红张辉.急性脑梗死患者B型脑钠肽的变化及其临床意义[J].中国实用神经疾病杂志,2018,21(4):424-426.
[21].Shibazaki K,Kimura K,Okada Y,et al.Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke[J].Interned,2009,48(18):1601-1606.
[22].Jabbarli R,Pierscianek D,Darkwah Oppong M,et al.Laboratory biomarkers of delayed cerebral ischemia after subarachnoid hemorrhage:a systematic review[J].Neurosurg Rev,?2018,Oct 10.DOI:10.1007/s10143-018-1037-y[Epub ahead of print].
[23].Terao Y,Oji M,Toyoda T,et al.An observational study of the association between microalbuminuria and increased N-terminal pro-B-type natriuretic peptide in patients with subarachnoid hemorrhage[J]. Intensive Care,2015,3:42.
[24].McAteer A,Hravnak M,Chang Y,et al.The Relationships between BNP and neurocardiac injury severity, noninvasive cardiac output, and outcomes after aneurysmal subarachnoid hemorrhage[J].Biol Res Nursing,2017,19(5):531-537.
[25].Duello KM,Nagel JP,Thomas CS,et al.Relationship of troponin T and age- and sex-adjusted BNP elevation following subarachnoid hemorrhage with 30-day mortality[J].Neurocrit Care,2015,23(1):59-65.
[26].Shibazaki K,Kimura K,Sakai K,et al.Plasma brain natriuretic peptide is elevated in the acute phase of intracerebral hemorrhage[J].J Clin Neurosci,2014,21(2):221-224.
[27].Gregorio T,Albuquerque I,Neves V,et al.NT-pro-BNP correlates with disease severity and predicts outcome in cerebral haemorrhage patients: Cohort study [J] .Neurol Sci,2019,399:51-56.
[28].Vestbo J, Hurd SS, Agusti A,et al. Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary.[J]. Am J Respir Crit Care Med,2007,176(4):347-365.
[29].Farghaly S,Galal M,Hasan AA.Brain natriuretic peptide as a predictor of weaning from mechanical ventilation in patients with respiratory illness[J].Aust Crit Care,2015,28(3):116-121.
[30].Edibo?lu ?. Can NT-proBNP levels predict prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit?[J].Balkan Med J,2018,35(6):422-426.
[31].Telo S,Kulu?ztürk M,Deveci F.The relationship between platelet-to-lymphocyte ratio and pulmonary embolism severity in acute pulmonary embolism[J].Int Angiol,2019,38(1):4-9.
[32]. Coutance G,le Page O,Lo T. Prognostic value of brain natriuretic peptide in acute pulmonary embolism[J].Crit Care,2008,12(4):R109.
[33].Tanabe Y,Obayashi T,Yamamoto T,et al. Predictive value of biomarkers for the prognosis of acute pulmonary embolism in Japanese patients:results of the Tokyo CCU Network registry[J].J Cardiol,2015,66(6):460-465.
[34].Pereira JM,Teixeira-Pinto A,Basílio C,et al.Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?[J].J Crit Care,2013,28(6):970-974.
[35].Klouche K,Pommet S,Amigues L,et al.Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock:relationships with systolic myocardial dysfunction and intensive care unit mortality[J].J Intensive Care Med,2014,29(4):229-237.
[36].Sun YZ,Gao YL,Yu QX,et al. Assessment of acute lung injury/acute respiratory distress syndrome using B-type brain natriuretic peptide[J].J Int Med Res,2015,43(6):802-808.
[37].Atalay C,Dogan N,Aykan S,et al. The efficacy of spironolactone in the treatment of acute respiratory distress syndrome-induced rats[J].Singapore Med J,2010,51(6):501-505.
[38].梁德金,李峥,梁裕积. BNP在有机磷农药中毒患者病情早期评估中的作用[J]. 中国医药指南,2017,10:184-185.
[39].Chen KX,Zhou XH,Sun CA. Manifestations of and risk factors for acute myocardial injury after acute organophosphorus pesticide poisoning[J].Medicine(Baltimore),2019,98(6):e14371.
[40].Wang Y,Wu Y,Shen F,et al.Clinical effect of haemoperfusion combined with continuous veno-veno haemofiltration in treatment of paraquat poisoning:a meta-analysis[J].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,2019,31(2):214-220.
[41].王珍珍. 血清NTpro-BNP、cTNI及IMA对急性百草枯中毒心肌损伤的诊断价值及预后评估[D].郑州大学,2011.
[42].Yücel M,Avsarogullari L,Durukan P,et al.BNP shows myocardial injury earlier than roponin-I in experimental carbon monoxide poisoning[J].Eur Rev Med Pharm Sci,2016,20(6):1149-1154.
[43].Beltrami M,Ruocco G,Ibrahim A,et al.Different trajectories and significance of B-type natriuretic peptide, congestion and acute kidney injury in patients with heart failure[J].Int Emerg Med,2017,12(5):593-603.
[44].[44] Kato K,Murakami H,Isozaki O,et al.Serum concentrations of BNP and ANP in patients with thyrotoxicosis[J].Endocr J,2009,56(1):17-27.